Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,378 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

NCT06577441

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Mills Health Center San Mateo, California, United States
View all 144 locations
View Trial Details
Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

NCT01174108

Conditions
Anemia, Anemia, Aplastic, Anemia, Hemolytic, +11 more
Locations
  • University of Maryland, Baltimore (UMB) Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

NCT04935684

Conditions
Acute Leukemia in Remission, Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud Amiens, France
  • Service Maladies du sang CHU Angers Angers, France
  • Hématologie clinique CHU Besançon Besançon, France
  • Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand Clermont-Ferrand, France
View all 20 locations
View Trial Details
Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT07422480

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope - Comprehensive Cancer Center (CCC) Duarte, California, United States
  • Providence Medical Group Santa Rosa, California, United States
  • University of Miami Miami, Florida, United States
View all 162 locations
View Trial Details
Recruiting

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

NCT05807932

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
Locations
  • Universitätsklinikum Aachen - Med. Klinik IV Aachen, North Rhine-Westphalia, Germany
  • Universitätsklinikum Düsseldorf - Klinik für Hämatologie, Onkologie und Klinische Immunologie Düsseldorf, North Rhine-Westphalia, Germany
  • Universitätsklinikum Köln Klinik I für Innere Medizin Cologne, Germany
  • Universitätsklinikum Frankfurt Medizinische Klinik II Frankfurt, Germany
View Trial Details

Related conditions